Orchid Pharma Limited Financial Overview
Orchid Pharma Limited's market cap is currently ₹40.96B. The company's EPS TTM is ₹-1.1; its P/E ratio is 76.13; Orchid Pharma Limited is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
